Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4

Infection and Immunity

Volumn 68, Issue 10, 2000, Pages 5496-5501

  Munson, E L ^a   Du Chateau, B K ^a   Jobe, D A ^a   Lovrich, S D ^a   Callister, S M ^a   Schell, R F ^a  

^a WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; BACTERIAL VACCINE; BACTERIUM ANTIBODY; CYTOKINE; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; MEMBRANE PROTEIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; DRUG EFFICACY; IMMUNOMODULATION; LYMPH NODE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTIBODIES, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI GROUP; CELLS, CULTURED; FORMALDEHYDE; INTERLEUKIN-4; LYME DISEASE; LYME DISEASE VACCINES; LYMPH NODES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C3H; RECOMBINANT PROTEINS; VACCINATION; VACCINES, INACTIVATED; VACCINES, SYNTHETIC;

EID: 0033796743     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.10.5496-5501.2000     Document Type: Article

References (35)

1. Nitric oxide suppresses human T lymphocyte proliferation through IFN-γ-dependent and IFN-γ-independent induction of apoptosis
2. Borrelia burgdorferi antigens that are targets of antibody-dependent, complement-mediated killing in the rhesus monkey
3. Isolation and cultivation of Lyme disease spirochetes
4. Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect B. burgdorferi
5. Importance of protective borreliacidal antibodies in Lyme disease immunity and serodiagnosis
6. The antibody response in Lyme disease: Evaluation of diagnostic tests
7. Occurrence of severe destructive Lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi
8. Western blotting in the serodiagnosis of Lyme disease
9. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease
10. Cutting edge: Mouse IgG1 antibodies comprise two functionally distinct types that are differentially regulated by IL-4 and IL-12
11. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA
12. 1, IgE, and IgG(2a)
13. 1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4
14. Interleukin-4 enhances anti-IgM stimulation of B cells by improving cell viability and by increasing the sensitivity of B cells to the anti-IgM signal
15. Murine B-cell stimulatory factor 1 (interleukin 4) increases expression of the Fc receptor for IgE on mouse B cells
16. Cleavage of the structural proteins during the assembly of the head of bacteriophage T4
17. Development of severe destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi
18. Interferon gamma plays a critical role in induced cell death of effector T cell: A possible third mechanism of self tolerance
19. Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection
20. Monoclonal antibodies with in vitro borreliacidal activities define the outer surface proteins A and B of Borrelia burgdorferi
21. Environmental signals influencing expression of the IFN-γ receptor on human T cells control whether IFN-γ promotes proliferation or apoptosis
22. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine
23. B-cell stimulating factor-1/interleukin 4
24. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen
25. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi
26. Animal and human antibodies reactive with the outer surface protein A and B of Borrelia burgdorferi are borreliacidal, in vitro, in presence of complement
27. The 39 kilodalton protein of Borrelia burgdorferi: A target for bactericidal human monoclonal antibodies
28. A vaccine consisting of recombinant Borrelia burgdorferi outer surface protein A to prevent Lyme disease
29. Recombinant outer surface protein A from Borrelia burgdorferi induces antibodies protective against spirochaetal infection in mice
30. Immunoglobulin class switching
31. The spirochetal etiology of Lyme disease
32. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant
33. Sera from OspA-vaccinated dogs, but not from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi
34. Inhibition of B cell receptor-mediated apoptosis by IFN